CGON vs JPM Stock Comparison

JPM currently leads CGON in this stock comparison, with AIQ scores of 65 vs 59. The clearest difference is quality.

Market data as of Nov 15, 2026 market close· AIQ score gap 6 points
CGON
Healthcare
vs
JPM
Financial Services
CGON
CG Oncology Inc.
Price
$74.40
Day move
+6.06%
AIQ Score
59/100
Best edge
Balanced
Sector
Healthcare
JPM
JPMorgan Chase & Co.
Leads
Price
$346
Day move
+0.98%
AIQ Score
65/100
Best edge
Quality
Sector
Financial Services

What is the main difference between CGON and JPM?

JPM leads the current stock comparison as JPMorgan Chase & Co., with the clearest separation coming from quality and the broader AIQ evidence mix.

AlgovestIQ AIQ Comparison

CG Oncology Inc. vs JPMorgan Chase & Co.

Data as of Nov 15, 2026· market close· Cross-sector · Healthcare vs Financial Services· Coverage 61/66 fields· High confidence
AIQ VerdictFragileAIQ Comparison Conviction 4/10

JPM leads

JPM leads by 6 AIQ points, primarily on Quality and Risk Resilience, but the lead has narrowed from 11 points over 30 sessions.

Fragile: 3 of 4 evidence groups support JPM, its lead is narrowing, and its current signal state is conflicted.

Evidence agreement: 3 of 4Comparison trend: Weakening
CGON

CG Oncology Inc.

AIQ Score
59/100
AIQ Edge Score
10/10
JPM

JPMorgan Chase & Co.

Leads
AIQ Score
65/100
AIQ Edge Score
8/10

The Algovestiq AIQ Score currently favors JPM over CGON, 65 versus 59 as of Nov 15, 2026. JPM's advantage is driven primarily by stronger quality and risk resilience. JPM also shows the weaker technical structure relative to its 50-day moving average. 3 of 4 covered evidence groups favor JPM today, and the comparison is rated Fragile on stability: the leader's advantage has been narrowing. JPM lead: Weakening — the AIQ differential moved from 11 to 6 points over 30 sessions.

Compare CG Oncology Inc. and JPMorgan Chase & Co. across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.

Currently unavailable

Performance over time

Total return with distributions reinvested, from daily closes.

CGON
+100.2%
JPM
+112.1%

Total return comparison

Growth of $10,000, distributions reinvested

CGON $20,016 · JPM $21,206

Split-adjusted closes; each distribution is reinvested at the close on its ex-dividend date. Taxes and trading costs are not modeled.

Compare CGON and JPM against another ticker

Open a multi-ticker workspace without changing this focused pair page.

Basic: 2 symbols·Explorer: 3 symbols·Pro and Premium: 5 symbols·Your limit: 2

AIQ Factor Divergence

Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.

CGON advantage
0
JPM advantage
  • Quality44 vs 86
    JPM +42
  • Risk Resilience59 vs 87
    JPM +28
  • Momentum71 vs 70
    Even

3 of 4 evidence groups favor JPM. JPM’s edge is concentrated in quality and risk resilience.

What changed since the last close

Latest scored session 2026-11-13, compared against the prior scored session 2026-11-12.

CGON+5 AIQ

Largest factor move: Momentum +10

New signals

  • ADX Trend Strengthening — neutral, trend, medium horizon
  • MACD Histogram Expanding Bullish — bullish, momentum, short horizon
  • Volume Surge - Bullish — bullish, volume, short horizon (2.74x)
JPM0 AIQ

Largest factor move: Momentum +1, not enough on its own to move the overall score.

New signals

  • Drawdown Recovery Signal — bullish, risk_regime, long horizon (-9.0%)
  • MACD Histogram Expanding Bullish — bullish, momentum, short horizon

JPM's lead narrowed by 5 AIQ points in the latest session.

Deeper signal detail for each name lives on its own signals page — CGON and JPM both carry a full feed there.

The central trade-off

JPM (JPMorgan Chase & Co.): the stronger current systematic profile, led by quality and risk resilience.

CGON (CG Oncology Inc.): the counter-case, on technicals — but at materially higher volatility, 75.8% against 27.4%.

Which one fits your objective

The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.

Balanced

JPM

JPM on the overall AIQ Score, which weights Quality and Value most heavily.

Growth

CGON

CGON on combined revenue and EPS growth.

Value

Even

The two are level on Value.

Momentum

Even

The two are level on Momentum.

Lower downside

JPM

JPM on Risk Resilience, by 28 points.

Analyst upside

Even

Analyst targets are level or not covered for both names.

AIQ vs Wall Street

Where the systematic read and the analyst consensus line up — and where they do not.

MeasureCGONJPMNote
Implied upside to target—+7.8%Level
Target dispersion—+30.3%Lower is tighter analyst agreement
ConsensusBuyBuyContext, not a primary driver
Analysts covering1526Higher coverage generally improves confidence

Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.

AIQ Agreement Matrix

3 of 4 covered evidence groups favor JPM. A wide gap backed by one group is a weaker case than a narrow gap backed by five.

Evidence groupFavorsReading
AIQ ScoreJPM59 vs 65
FundamentalsJPMon balancerevenue growth 38.6% vs -7.6%; EPS growth 28.9% vs -27.6%; TTM ROE -5.7% vs 4.1%; gross margin -102.2% vs 63.2%; operating margin -42.9% vs 28.2% — JPM takes 3 of 5 decided legs, not all of them
ValuationNot coveredNot covered
TechnicalsCGONPrice vs 50-day 9.3% vs 1.7%; vs 200-day 11.6% vs 6.6%
Risk ResilienceJPMRisk Resilience 59 vs 87
Analyst expectationsNot coveredNot covered

✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of CGON and JPM and are excluded from the count.

AIQ Decision Stability

Fragile

The conclusion is sensitive to small changes. Treat the lead as provisional and watch the flip conditions below.

  • The AIQ gap is moderate at 6 points.
  • The leader's advantage has been narrowing. (argues the conclusion is provisional)
  • The lead has been steady session to session. (supports the conclusion holding)
  • The leader is throwing conflicting signals. (argues the conclusion is provisional)

Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on JPM.

How the comparison changed

120 daily snapshots · May 27 – Nov 13

JPM lead: Weakening — the AIQ differential moved from 11 to 6 points over 30 sessions.

May 27CGON leads above the line · JPM leads belowNov 13
Today
JPM +6
59 vs 65
7 sessions ago
JPM +10
54 vs 64
30 sessions ago
JPM +11
52 vs 63
90 sessions ago
Level
64 vs 64

The lead changed hands once in this window, most recently on Aug 27 when CGON moved ahead of JPM.

AIQ Signal Divergence

Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.

CGON

7 bullish / 0 bearish / 2 neutral

Only CGON

  • ADX Trend Strengthening — neutral, trend, medium horizon
  • ATR Expansion - Breakout Mode — neutral, volatility, short horizon (5.89%)
  • Accumulation Pattern — bullish, volume, medium horizon (2.74x)
  • Volume Surge - Bullish — bullish, volume, short horizon (2.74x)
JPMConflicted

6 bullish / 1 bearish / 1 neutral, conflicted

Only JPM

  • Bollinger Band Squeeze — neutral, volatility, short horizon (5.9%)
  • Drawdown Recovery Signal — bullish, risk_regime, long horizon (-9.0%)
  • Low Volume Rally Warning — bearish, volume, short horizon (0.65x)

Both carry 5 more signals that do not separate them: Golden Cross Active, EMA Ribbon Expansion Bullish, MACD Histogram Expanding Bullish, TRIX Bullish Signal, Uptrend Structure Active.

JPM leads the comparison while carrying a conflicted signal state, which is one reason the stability rating is not higher.

Price vs model alignment

Whether the latest session's price move confirms what the model did over the same session, or contradicts it.

CGONConfirmed strength

Price and the AIQ Score both moved up over the latest session (price +6.06%, AIQ +5 points).

JPMNo material change

Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price +0.98%, AIQ 0 points).

What would flip this result

A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.

  1. 1CGON closes the Quality gap — currently 42 points behind, the largest single contributor to JPM's edge.
  2. 2CGON generates a confirmed bullish trend signal it does not currently carry, such as MACD Bullish Crossover.
  3. 3JPM's conflicting signal state resolves bearish — it currently carries 6 bullish and 1 bearish rules at once.
  4. 4The narrowing continues — the lead has already given back 5 points over 30 sessions, and a further 6-point move would eliminate JPM's advantage entirely.

The full evidence

Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.

Fundamentals

JPM leads on balance
MetricCGONJPM
Revenue growth (YoY)38.6%-7.6%
EPS growth (YoY)28.9%-27.6%
Gross margin-102.2%63.2%
Operating margin-42.9%28.2%
Return on equity (TTM)-5.7%4.1%
Debt to equity0.013.32

Performance

CGON leads 4 of 6 windows
MetricCGONJPM
1 week (5 sessions)-2.1%3.5%
1 month (20 sessions)24.3%1.9%
3 months (63 sessions)-3.5%-4.1%
6 months (126 sessions)11.2%16.2%
Year to date79.2%7.4%
1 year (252 sessions)88.8%8%

Technicals

CGON has the stronger structure
MetricCGONJPM
RSI (14)61.356.1
ADX (14)24.918
Price vs 50-day9.3%1.7%
Price vs 200-day11.6%6.6%
Volatility (1M, annualized)75.8%27.4%

Risk

JPM is the more resilient
MetricCGONJPM
Beta1.040.78
Sharpe ratio1.380.44
Sortino ratio2.550.61
Max drawdown-27.4%-15.5%
Current drawdown-7.8%-5.2%
Annualized volatility58.4%22.7%
Value at risk (95%)-4.6%-2.4%

Straight answers

Each answer is regenerated from the current snapshot, not written once and left to age.

Which is better, CGON or JPM?

On the Algovestiq AIQ Score, JPM is the stronger of the two as of Nov 15, 2026, scoring 65 against CGON's 59. The edge comes from quality and risk resilience. This is a systematic score, not a recommendation: it ranks the two on the same evidence, it does not know your holding period or tax position.

Is CGON or JPM the better buy right now?

JPM carries the stronger systematic profile as of Nov 15, 2026, and the comparison is rated Fragile — 3 of 4 covered evidence groups agree. A Fragile rating means the conclusion is sensitive: the leader's advantage has been narrowing. Treat the lead as provisional.

Why does the AIQ Score favor JPM over CGON?

The composite weights Quality, Value, Momentum and Risk Resilience. JPM leads Quality by 42 points; JPM leads Risk Resilience by 28 points. Where the two split, the factor with the larger weight carries the result.

Which has more analyst upside, CGON or JPM?

Analyst price targets imply not covered upside for CGON and +7.8% for JPM. The model and the Street agree here, which is a broader base of evidence than either alone. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.

Which is better value, CGON or JPM?

Neither name separates on the peer-relative Value factor. The two are level on Value. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.

Which has stronger growth, CGON or JPM?

CGON on combined revenue and EPS growth. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.

Which has stronger momentum, CGON or JPM?

The two are level on Momentum. Momentum is one of the four weighted factors in the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.

Which is riskier, CGON or JPM?

JPM is the more resilient of the two, so the other name carries the higher downside risk. JPM on Risk Resilience, by 28 points. Risk Resilience is a weighted factor in the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.

Is CGON more profitable than JPM?

JPM leads on the comparable margin measures — gross margin -102.2% vs 63.2%; operating margin -42.9% vs 28.2%; ttm roe -5.7% vs 4.1%.

Is JPM's lead over CGON getting stronger or weaker?

JPM lead: Weakening — the AIQ differential moved from 11 to 6 points over 30 sessions. This is measured from 120 daily comparison snapshots between 2026-05-27 and 2026-11-13. The lead has changed hands once in that window, most recently on 2026-08-27, when CGON moved ahead of JPM.

What would change the CGON vs JPM verdict?

The result is a state, not a forecast, so it changes when the underlying evidence changes. Concretely: CGON closes the Quality gap — currently 42 points behind, the largest single contributor to JPM's edge; CGON generates a confirmed bullish trend signal it does not currently carry, such as MACD Bullish Crossover; JPM's conflicting signal state resolves bearish — it currently carries 6 bullish and 1 bearish rules at once; the narrowing continues — the lead has already given back 5 points over 30 sessions, and a further 6-point move would eliminate JPM's advantage entirely.

What do the current signals say about CGON and JPM?

CGON: 7 bullish / 0 bearish / 2 neutral. JPM: 6 bullish / 1 bearish / 1 neutral, conflicted. A conflicted state means bullish and bearish rules are active on the same name at once — the technical evidence is not pointing one way, and a decision taken on it carries more timing risk. The most decision-relevant rule on CGON is Golden Cross Active (bullish, long horizon). On JPM it is Golden Cross Active (bullish, long horizon).

Compare CGON and JPM with others

Continue your research

This page answers which of the two. These answer the questions on either side of it.

How this comparison is scored

The Algovestiq AIQ Score composites four factors — Quality, Value, Momentum and Risk, each carrying a fixed weight. Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.

The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.

How to use side-by-side comparison →

This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.